c-Met antisense oligodeoxynucleotides increase sensitivity of human glioma cells to paclitaxel

Oncology Reports

Volumn 24, Issue 1, 2010, Pages 189-194

  Chu, Sheng Hua ^a   Ma, Yan Bin ^a   Feng, Dong Fu ^a   Zhang, Hong ^a   Qiu, Jian Hua ^a   Zhu, Zhi An ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antisense oligonucleotide; Apoptosis; c Met; Glioma; Paclitaxel

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; PACLITAXEL; SCATTER FACTOR RECEPTOR; ANTINEOPLASTIC AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE;

ANTISENSE THERAPY; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER GENE THERAPY; CANCER INHIBITION; CHEMOSENSITIVITY; CHEMOSENSITIZATION; CONTROLLED STUDY; DRUG POTENTIATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE INDUCTION; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TUMOR GROWTH; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BRAIN NEOPLASMS; CELL PROLIFERATION; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; GENETICS; GLIOMA; METABOLISM; PATHOLOGY; TUMOR CELL CULTURE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BRAIN NEOPLASMS; CASPASE 3; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PACLITAXEL; PROTO-ONCOGENE PROTEINS C-MET; TUMOR CELLS, CULTURED;

EID: 77952993639     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000845     Document Type: Article

References (27)

1. Giannopoulos T, Butler-Manuel S, Taylor A, Ngeh N and Thomas H: Clinical outcomes of neoadjuvant chemotherapy and primary debulking surgery in advanced ovarian carcinoma. Eur J Gynaecol Oncol 27: 25-28, 2006.
2. Petrek JA, Naughton MJ, Case LD, Paskett ED, Naftalis EZ, Singletary SE and Sukumvanich P: Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 24: 1045-1051, 2006.
3. Paccagnella A, Oniga F, Bearz A, et al: Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small cell lung cancer: results of a phase II-III study. J Clin Oncol 24: 681-687, 2006. (Pubitemid 46630434)
4. Schmidt M, Schler G, Gruensfelder P, Favaretto A, Clerici M, Barbieri F, Riccardi A, Chella A, Tirelli U, Ceresoli G, Tumolo S, Ridolfi R, Biason R, Nicoletto MO, Belloni P, Veglia F and Ghi MG: Differential gene expression in a paclitaxel-resistant clone of a head and neck cancer cell line. Eur Arch Otorhinolaryngol 263: 127-134, 2006. (Pubitemid 43168185)
5. Li PK, Pandit B, Sackett DL and Hoppe F: A thalidomide analogue with in vitro antiproliferative, antimitotic and microtubule-stabilizing activities. Mol Cancer Ther 5: 450-456, 2006.
6. Tabata H: Paclitaxel production by plant-cell-culture technology. Adv Biochem Eng Biotechnol 87: 1-23, 2004.
7. Yoshiike F, Koizumi T, Kitaguchi Y, Hatayama O, Yasuo M, Sasabayashi M, Wakamatsu H, Fujimoto K and Kubo K: Phase I trial of nedaplatin and paclitaxel for patients with non-small cell lung cancer. J Chemother 17: 550-554, 2005. (Pubitemid 41695603)
8. Chu SH, Yuan XH, Jiang PC, Li ZQ, Zhang J, Wen ZH, Zhao SY, Chen XJ and Cao CJ: The expression of hepatocyte growth factor and its receptor in brain astrocytomas. Zhonghua Yi Xue Za Zhi 85: 835-838, 2005. (Pubitemid 40484874)
9. Chu SH, Yuan XH, Li ZQ, Jiang P and Zhang J: C-Met antisense oligodeoxynucleotide inhibits growth of glioma cells. Surg Neurol 65: 533-538, 2006. (Pubitemid 43729600)
10. Chu SH, Zhang H, Ma YB, Feng DF, Zhu ZA, Yuan XH and Li ZQ: C-Met antisense oligodeoxynucleotides as a novel therapeutic agent for glioma: in vitro and in vivo studies of uptake, effects and toxicity. J Surg Res 141: 284-288, 2007. (Pubitemid 47042052)
11. Chu SH, Zhu ZA, Yuan XH, Feng DF, Zhu ZA, Yuan XH and Li ZQ: In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotides. J Neurooncol 80: 143-149, 2006.
12. Chu SH, Ma YB, Zhang H, Feng DF, Zhu ZA, Li ZQ and Yuan XH: Hepatocyte growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells. J Neurooncol 85: 33-38, 2007. (Pubitemid 47422654)
13. Chu SH, Ma YB, Zhu ZA, Zhang H, Feng DF, Li ZQ and Yuan XH: Radiation-enhanced hepatocyte growth factor secretion in malignant glioma cell lines. Surg Neurol 68: 610-613, 2007.
14. Chu SH, Yuan XH and Jiang PC: Recombinant human hepatocyte growth factor in cellular apoptosis of glioma induced by mitomycin C. Chin J Neuromed 4: 1093-1096, 2005.
15. Jiang PC, Chu SH and Yuan XH: The c-met protooncogene antisense oligodeoxynucleotide enhances the sensitivity of glioma cell U251 to mitomycin C. Chin J Exp Surg 23: 540-542, 2006.
16. WAF-mediated cell cycle arrest. Oncogene 27: 116-125, 2008.
17. Terzis AJ, Thorsen F, Heese O, Visted T, Bjerkvig R, Dahl O, Arnold H and Gundersen G: Proliferation, migration and invasion of human glioma cells exposed to paclitaxel (Taxol) in vitro. Br J Cancer 75: 1744-1752, 1997. (Pubitemid 27230698)
18. Fueyo J, Gomez-Manzano C, Puduvalli VK, Martin-Duque P, Perez-Soler R, Levin VA, Yung WK and Kyritsis AP: Adenovirus-mediated p16 transfer to glioma cells induces G1 arrest and protects from paclitaxel and topotecan: implications for therapy. Int J Oncol 12: 665-669, 1998. (Pubitemid 28097299)
19. Chung WH, Sung BH, Kim SS, Rhim H and Kuh HJ: Synergistic interaction between tetra-arsenic oxide and paclitaxel in human cancer cells in vitro. Int J Oncol 34: 1669-1679, 2009.
20. Li JJ and Zhao JZ: Comparison between the expression of apotosis-related factor of BT325 human glioblastoma and U251 glioblastoma. J Cap Med Univ 29: 45-48, 2008.
21. Cassinelli G, Supino R, Zuco V, Lanzi C, Scovassi AI, Semple SC and Zunino F: Role of c-myc protein in hormone refractory prostate carcinoma: cellular response to paclitaxel. Biochem Pharmacol 68: 923-931, 2004. (Pubitemid 39044519)
22. Ray S, Lu Y, Kaufmann SH, et al: Genomic mechanisms of p210BCR-ABL signaling: induction of heat shock protein 70 through the GATA response element confers resistance to paclitaxel-induced apoptosis. J Biol Chem 279: 35604-35615, 2004. (Pubitemid 39100562)
23. Cui W, Wu R, Cao H, Gustafson WC, Karp JE, Boldogh I, Fields AP and Brasier AR: P53 gene mutation and expression of MDM2, P53, P16 protein and their relationship in human glioma. J Huazhong Univ Sci Technolog Med Sci 25: 622-624, 2005.
24. Broaddus WC, Prabhu SS, Gillies GT, Neal J, Conrad WS, Chen ZJ, Fillmore H and Young HF: Distribution and stability of antisense phosphorothioate oligonucleotides in rodent brain following direct intraparenchymal controlled-rate infusion. J Neurosurg 88: 734-742, 1998. (Pubitemid 28145218)
25. Laske DW, Youle RJ and Oldfield EH: Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3: 1362-1368, 1997.
26. Prados MD, Schold SC, Spence AM, Berger MS, McAllister LD, Mehta MP, Gilbert MR, Fulton D, Kuhn J, Lamborn K, Rector DJ and Chang SM: Phase II study of paclitaxel in patients with recurrent malignant glioma. J Clin Oncol 14: 2316-2321, 1996. (Pubitemid 26264883)
27. Tishler RB, Geard CR, Hall EJ and Schiff PB: Taxol sensitizes human astrocytoma cells to radiation. Cancer Res 52: 3495-3497, 1992.